MEDICAL LASER SYSTEMS MARKET ANALYSIS

Market News

Global Medical Laser Systems Market: Key Developments

On February 23, 2023, BIOLASE, Inc., a medical device company, announced the U.S. launch of the Waterlase Fractional Handpiece for doctors seeking a faster and more efficient way to perform skin resurfacing. The Waterlase Fractional Handpiece is U.S. FDA 510(k) cleared and built on the patented and proven Waterlase iPlus platform, the leading all-tissue laser in the marketplace. The hand piece can deliver both ablative and non-ablative fractional treatments and provides the doctor with control over the depth of penetration with different parameters and treatment techniques.

In June 2020, LUMIBIRD, a developer, and manufacturer of markets lasers acquired all of Ellex’s laser and ultrasound activities, including the Ellex brand, the R&D and production site in Adelaide and the commercial subsidiaries based in Australia, Japan, the US, France, and Germany. In addition to the scale effect, this alliance represents a strong value-creating project thanks to their complementary product ranges, R&D, and commercial presence. Through this acquisition, the Group has further strengthened its current range with complementary high-quality products, while extending its geographical presence, particularly in the US and Japan, which are the top two global markets for ophthalmological medical devices.

On May 08, 2023, Reveal Lasers LLC, an energy-based technology for medical and aesthetic procedures company, announced the acquisition of Med Rep Meeting, a start-up company that arranges meetings for medical representatives in industries including medical aesthetics. This acquisition will allow Med Rep Meeting to act as the inside sales team for Reveal Lasers, enhancing the efficiency and productivity of Reveal Lasers' sales reps in the field.

In July 2022, STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announced the U.S. commercial launch of TheraClearX, a non-invasive, in-office acne treatment targeting the root causes of mild to moderate acne, including comedonal, pustular and inflammatory acne vulgaris.

In June 2020, Cynosure, Inc. a developer and manufacturer of light-based aesthetic and medical treatment systems, announced the U.S., European, and Australian launch of the Elite iQ platform, the next generation of the Elite+ Aesthetic Workstation that allows for faster treatments with higher max energy compared to previous generation devices. The Elite iQ platform leverages Skintel, the aesthetic industry's only live Melanin Reader, to offer customized laser hair removal treatments and permanently reduce unwanted hair for all skin types, anywhere on the body including the face, back, chest, arms, underarms, bikini area, and legs.